Pharvaris
(NASDAQ) PHVS
Pharvaris Financials at a Glance
Market Cap
$2.15B
Revenue (TTM)
€0.00
Net Income (TTM)
-€169.20M
EPS (TTM)
-$3.18
P/E Ratio
-9.79
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$31.65
Volume
552,722
Open
$31.13
Price
$31.65
Volume
552,722
Open
$31.13
Previous Close
$31.59
Daily Range
$30.78 - $31.83
52-Week Range
$16.00 - $33.33
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$31.65
Volume
552,722
Open
$31.13
Previous Close
$31.59
Daily Range
$30.78 - $31.83
52-Week Range
$16.00 - $33.33
Estimated Earnings Date
Aug 11, 2026
PHVS News
PHVS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pharvaris
Industry
Pharmaceuticals
Sector
Health CareEmployees
129
CEO
Berndt A. E. Modig, MBA, CPA
Website
www.pharvaris.comHeadquarters
Leiden, 2333 CH, NL
PHVS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-76%
Return on Capital
-73%
Return on Assets
-65%
Earnings Yield
-10.21%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.15B
Shares Outstanding
69.28M
Volume
552.72K
Avg. Volume
295.66K
Financials (TTM)
Gross Profit
€0.00
Operating Income
-€169.82M
EBITDA
-€169.40M
Operating Cash Flow
-€137.07M
Capital Expenditure
-€164.62K
Free Cash Flow
-€137.24M
Cash & ST Invst.
€291.68M
Total Debt
€776.80K
Pharvaris Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€0.00
N/A
Gross Profit
-€106.45K
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.15B
N/A
Market Cap/Employee
$19.94M
N/A
Employees
108
N/A
Net Income
-€39.85M
+14.0%
EBITDA
-€44.89M
-6.7%
Quarterly Fundamentals
Net Cash
€246.22M
+4.4%
Accounts Receivable
€4.98M
+88.2%
Inventory
€0.00
N/A
Long Term Debt
€532.58K
-2.5%
Short Term Debt
€206.31K
+6.0%
Return on Assets
-65.13%
N/A
Return on Invested Capital
-72.88%
N/A
Free Cash Flow
-€49.62M
-28.4%
Operating Cash Flow
-€49.57M
-28.8%